Regen Biopharma, Inc. — Regulation A 1-A
Regen Biopharma, Inc. of La Mesa, CA filed a Regulation A 1-A with the SEC on 2025-11-17. Aggregate offering: $1.3M (Tier 2). Industry: Other.
Offering
- Filed: 2025-11-17
- Form: 1-A
- Accession: 0001493152-25-023753
- Tier: Tier 2
- Total aggregate offering: $1.3M
- Issuer portion: $1.0M
- Price per security: $0.0100
- Securities offered: Equity (common or preferred stock)
- Audit status: Audited
- Auditor: BCRG Group (PCAOB ID 7158)
- Jurisdictions: 52 states/territories
Issuer
- CIK: 0001589150
- Organized in: NV
- Incorporated: 2012
- Address: 4700 Spring Street, La Mesa, CA, 91942
- Phone: 619-722-5505
- Employees: 1 full-time
Financial snapshot (as filed)
- Total assets: $197K
- Cash & equivalents: $2K
- Total liabilities: $6.0M
- Stockholder equity: $-5.8M
- Revenues: $177K
- Net income: $-702K
People (1)
| Name | Role | Location |
|---|
| David R Koos | Signer | La Mesa, CA |
Other Reg A filings by this issuer (6)
More